Robert Charles Breedlove Phathom Pharmaceuticals, Inc. (PHAT) insider trading activity

PHAT Quotes by TradingView

Robert Charles Breedlove is Principal Accounting Officer of Phathom Pharmaceuticals, Inc.. Currently has a direct ownership of 47,844 shares of PHAT, which is worth approximately $702,828. The most recent transaction as insider was on Dec 18, 2025, when has been sold 230 shares (Common Stock) at a price of $16.28 per share, resulting in proceeds of $3,744. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.8K
0.18% 3M change
n/a 12M change
Total Value Held $702,828

Robert Charles Breedlove Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2025
SELL
Payment of exercise price or tax liability
$3,744 $16.28 p/Share
230 Reduced 0.48%
47,844 Common Stock
Nov 03 2025
SELL
Open market or private sale
$7,079 $13.51 p/Share
524 Reduced 1.09%
47,407 Common Stock
Sep 05 2025
SELL
Open market or private sale
$5,573 $12.09 p/Share
461 Reduced 0.95%
47,931 Common Stock
Jul 16 2025
SELL
Open market or private sale
$14,145 $8.36 p/Share
1,692 Reduced 3.38%
48,392 Common Stock
RCB

Robert Charles Breedlove

Principal Accounting Officer
Florham Park, NJ

Track Institutional and Insider Activities on PHAT

Follow Phathom Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAT shares.

Notify only if

Insider Trading

Get notified when an Phathom Pharmaceuticals, Inc. insider buys or sells PHAT shares.

Notify only if

News

Receive news related to Phathom Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHAT